journal article·2021-12Open access

Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T‐Cell Responses

Xuedan He, Shiqi Zhou, Breandan Quinn, Wei‐Chiao Huang, Dushyant Jahagirdar, Michael Vega, Joaquin Ortega, Mark D. Long, Fumito Ito, Scott I. Abrams, Jonathan F. Lovell

Advanced Science· Volume 8· Issue 24

Abstract

Abstract Short peptides reflecting major histocompatibility complex (MHC) class I (MHC‐I) epitopes frequently lack sufficient immunogenicity to induce robust antigen (Ag)‐specific CD8+ T cell responses. In the current work, it is demonstrated that position‐scanning peptide libraries themselves can serve as improved immunogens, inducing Ag‐specific CD8+ T cells with greater frequency and function than the wild‐type epitope. The approach involves displaying the entire position‐scanning library onto immunogenic nanoliposomes. Each library contains the MHC‐I epitope with a single randomized position. When a recently identified MHC‐I epitope in the glycoprotein gp70 envelope protein of murine leukemia virus (MuLV) is assessed, only one of the eight positional libraries tested, randomized at amino acid position 5 (Pos5), shows enhanced induction of Ag‐specific CD8+ T cells. A second MHC‐I epitope from gp70 is assessed in the same manner and shows, in contrast, multiple positional libraries (Pos1, Pos3, Pos5, and Pos8) as well as the library mixture give rise to enhanced CD8+ T cell responses. The library mixture Pos1‐3‐5‐8 induces a more diverse epitope‐specific T‐cell repertoire with superior antitumor efficacy compared to an established single mutation mimotope (AH1‐A5). These data show that positional peptide libraries can serve as immunogens for improving CD8+ T‐cell responses against endogenously expressed MHC‐I epitopes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · vaccines and immunoinformatics approaches · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University at Buffalo State University of New York Buffalo NY 14260 USA

Department of Anatomy and Cell Biology McGill University Montreal Quebec H3A1Y2 Canada

Division of Research and Innovation Partnerships Northern Illinois University DeKalb IL 60115 USA

Department of Cancer Genetics and Genomics Roswell Park Comprehensive Cancer Center (RPCCC) Buffalo NY 14263 USA

Department of Immunology Roswell Park Comprehensive Cancer Center Buffalo NY 14263 USA

Center for Immunotherapy Roswell Park Comprehensive Cancer Center Buffalo NY 14263 USA

Department of Surgical Oncology Roswell Park Comprehensive Cancer Center Buffalo NY 14263 USA

Funding

National Institutes of Health · McGill University

References (80)

Show source-provided references
1. 10.1002/advs.20180184710.1002/advs.201801847 ↗
2. 10.1002/advs.20170042610.1002/advs.201700426 ↗
3. 10.1002/advs.20190330110.1002/advs.201903301 ↗
4. 10.1002/advs.20170099110.1002/advs.201700991 ↗
5. 10.1002/adbi.20180021910.1002/adbi.201800219 ↗
6. 10.1002/adtp.20180006010.1002/adtp.201800060 ↗
7. 10.1016/j.coi.2016.11.00110.1016/j.coi.2016.11.001 ↗
8. 10.1016/j.vaccine.2007.01.03310.1016/j.vaccine.2007.01.033 ↗
9. 10.1182/blood.V97.6.177610.1182/blood.V97.6.1776 ↗
10. Pinilla C. · BioTechniques · 1992 · 13 · 901
11. 10.1042/bst023067810.1042/bst0230678 ↗
12. 10.4049/jimmunol.157.2.67010.4049/jimmunol.157.2.670 ↗
13. 10.1084/jem.184.1.12110.1084/jem.184.1.121 ↗
14. Wiesmüller K.‐H. · J. Biol. Chem. · 2001 · 382 · 571
15. 10.1002/1521-4141(200208)32:8<2292::AID-IMMU2292>3.0.CO;2-K10.1002/1521-4141(200208)32:8<2292::AID-IMMU2292>3.0.CO;2-K ↗
16. 10.4049/jimmunol.169.10.569610.4049/jimmunol.169.10.5696 ↗
17. McMahan R. H. · J. Clin. Invest. · 2006 · 116 · 2543
18. 10.1371/journal.pone.015646210.1371/journal.pone.0156462 ↗
19. 10.4049/jimmunol.162.3.174910.4049/jimmunol.162.3.1749 ↗
20. 10.1002/eji.20042513410.1002/eji.200425134 ↗
21. 10.1007/s00262-006-0191-110.1007/s00262-006-0191-1 ↗
22. 10.1016/S1074-7613(00)00052-210.1016/S1074-7613(00)00052-2 ↗
23. 10.4049/jimmunol.160.4.175010.4049/jimmunol.160.4.1750 ↗
24. 10.4049/jimmunol.157.6.253910.4049/jimmunol.157.6.2539 ↗
25. 10.4049/jimmunol.165.2.94810.4049/jimmunol.165.2.948 ↗
26. 10.1158/1078-0432.CCR-10-327210.1158/1078-0432.CCR-10-3272 ↗
27. 10.1186/1479-5876-12-9710.1186/1479-5876-12-97 ↗
28. 10.1158/1078-0432.CCR-12-151610.1158/1078-0432.CCR-12-1516 ↗
29. 10.1056/NEJMoa101286310.1056/NEJMoa1012863 ↗
30. 10.1126/scitranslmed.aau551610.1126/scitranslmed.aau5516 ↗
31. Probst P. · Eur. J. Immunol. · 2019 · 50 · 1591
32. 10.1128/JVI.43.1.26-36.198210.1128/JVI.43.1.26-36.1982 ↗
33. 10.4161/onci.2688910.4161/onci.26889 ↗
34. 10.1073/pnas.93.18.973010.1073/pnas.93.18.9730 ↗
35. 10.1016/j.vaccine.2008.01.05210.1016/j.vaccine.2008.01.052 ↗
36. 10.1016/j.immuni.2015.05.00110.1016/j.immuni.2015.05.001 ↗
37. 10.1073/pnas.091487910710.1073/pnas.0914879107 ↗
38. 10.1002/eji.20114177410.1002/eji.201141774 ↗
39. 10.1074/jbc.M113.50955410.1074/jbc.M113.509554 ↗
40. 10.1111/j.0105-2896.2006.00365.x10.1111/j.0105-2896.2006.00365.x ↗
41. 10.4161/hv.2967910.4161/hv.29679 ↗
42. 10.1016/j.imlet.2018.10.00810.1016/j.imlet.2018.10.008 ↗
43. 10.4049/jimmunol.174.8.481210.4049/jimmunol.174.8.4812 ↗
44. 10.4049/jimmunol.180.3.152610.4049/jimmunol.180.3.1526 ↗
45. 10.1371/journal.pmed.001002810.1371/journal.pmed.0010028 ↗
46. 10.4049/jimmunol.170022810.4049/jimmunol.1700228 ↗
47. 10.1080/14760584.2016.121363210.1080/14760584.2016.1213632 ↗
48. 10.1038/s41565-018-0271-310.1038/s41565-018-0271-3 ↗
49. 10.1038/s41541-020-0173-x10.1038/s41541-020-0173-x ↗
50. 10.1016/j.vaccine.2019.10.07310.1016/j.vaccine.2019.10.073 ↗
51. 10.1002/adma.20200563710.1002/adma.202005637 ↗
52. 10.1073/pnas.202575911810.1073/pnas.2025759118 ↗
53. 10.1021/acsnano.0c0768010.1021/acsnano.0c07680 ↗
54. 10.1002/smll.20200716510.1002/smll.202007165 ↗
55. 10.1021/jp002151u10.1021/jp002151u ↗
56. 10.1016/j.ijpharm.2010.10.02510.1016/j.ijpharm.2010.10.025 ↗
57. 10.1093/bioinformatics/btv63910.1093/bioinformatics/btv639 ↗
58. 10.1110/ps.023940310.1110/ps.0239403 ↗
59. 10.1038/ncomms1384810.1038/ncomms13848 ↗
60. 10.1084/jem.176.6.168110.1084/jem.176.6.1681 ↗
61. Fahmy T. M. · J. Immun. · 2001 · 14 · 135
62. 10.1016/j.immuni.2007.07.01010.1016/j.immuni.2007.07.010 ↗
63. 10.1158/0008-5472.CAN-12-410010.1158/0008-5472.CAN-12-4100 ↗
64. 10.1126/science.aaa382810.1126/science.aaa3828 ↗
65. 10.1038/nature2299110.1038/nature22991 ↗
66. 10.1038/nature2300310.1038/nature23003 ↗
67. 10.1080/2162402X.2018.156110610.1080/2162402X.2018.1561106 ↗
68. 10.1038/s41591-020-01206-410.1038/s41591-020-01206-4 ↗
69. 10.1038/s41586-020-2537-910.1038/s41586-020-2537-9 ↗
70. 10.1038/nature1442610.1038/nature14426 ↗
71. 10.1016/0022-1759(90)90464-710.1016/0022-1759(90)90464-7 ↗
72. 10.1073/pnas.88.9.397210.1073/pnas.88.9.3972 ↗
73. 10.1038/nbt.259310.1038/nbt.2593 ↗
74. 10.1038/s41467-019-12369-110.1038/s41467-019-12369-1 ↗
75. 10.1038/nchem.223610.1038/nchem.2236 ↗
76. 10.1038/s41467-021-21619-010.1038/s41467-021-21619-0 ↗
77. D.CoffeyR package version 1.14.0. 2019.
78. Morisita M. · Mem. Fac. Sci., Kyushu Univ., Ser. E · 1959 · 2 · 5
79. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
80. 10.1158/2326-6066.CIR-17-011410.1158/2326-6066.CIR-17-0114 ↗